홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-(Cyclopropylcarbonyl)piperidine-4-carboxylic acid → N-[(3R,4R)-1-{[1-(cyclopropylcarbonyl)piperidin-4-yl]carbonyl}-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methyl-4-(trifluoromethyl)benzamide

HRID 1260993
인쇄

반응식

HRID 1260993 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C@H:9]2[C@H:14]([N:15]([CH3:28])[C:16](=[O:27])[C:17]3[CH:22]=[CH:21][C:20]([C:23]([F:26])([F:25])[F:24])=[CH:19][CH:18]=3)[CH2:13][CH2:12][NH:11][CH2:10]2)[CH:5]=[CH:6][C:7]=1[Cl:8].[CH:29]1([C:32]([N:34]2[CH2:39][CH2:38][CH:37]([C:40](O)=[O:41])[CH2:36][CH2:35]2)=[O:33])[CH2:31][CH2:30]1>>[CH:29]1([C:32]([N:34]2[CH2:35][CH2:36][CH:37]([C:40]([N:11]3[CH2:12][CH2:13][C@@H:14]([N:15]([CH3:28])[C:16](=[O:27])[C:17]4[CH:22]=[CH:21][C:20]([C:23]([F:26])([F:24])[F:25])=[CH:19][CH:18]=4)[C@H:9]([C:4]4[CH:5]=[CH:6][C:7]([Cl:8])=[C:2]([Cl:1])[CH:3]=4)[CH2:10]3)=[O:41])[CH2:38][CH2:39]2)=[O:33])[CH2:30][CH2:31]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 89029151-(Cyclopropylcarbonyl)piperidine-4-carboxylic acidHCID 68934058N-[(3R,4R)-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methyl-4-(trifluoromethyl)benzamide

생성물 1

HCID 68930394N-[(3R,4R)-1-{[1-(cyclopropylcarbonyl)piperidin-4-yl]carbonyl}-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methyl-4-(trifluoromethyl)benzamide

실험 절차

Using the compound obtained in step 1 and 1-(cyclopropylcarbonyl)piperidine-4-carboxylic acid, and by the reaction and purification in the same manner as in Example 97, the title compound was obtained.

후처리

  1. customby the reaction and purification in the same manner as in Example 97

출처 및 근거

ORD 기록
ord-124ee376ccb349b3b91589f9b7d27db1
출처 데이터셋
uspto-grants-2013_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08470816B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트